Draft:Oramed Pharmaceuticals

Apr 29, 2019

Oramed to Present at ThinkEquity Conference

Apr 04, 2019

Oramed Patent Allowed in the U.S. for Oral Exenatide

Apr 03, 2019

Oramed to Present at H.C. Wainwright Global Life Sciences Conference

Mar 28, 2019

Oramed Patent Allowed in the U.S. for Key Aspect of Its Oral Delivery Technology

Nov 13, 2018

Oramed Completes Over 50% Randomization in Its Pivotal 90-Day Clinical Study

Nov 05, 2018

Oramed to Present at the Tides Europe 2018 Conference

Oct 23, 2018

Oramed to Present at Cardiometabolic Health Congress

Oct 04, 2018

Oramed Enrolls First Patient in Its Clinical Study for Oral Insulin in the Treatment of NASH

Sep 17, 2018

Oramed Receives FDA Clearance for IND Application for Its Oral GLP-1 Analog Capsule

Aug 28, 2018

Oramed to Present at the H.C. Wainwright Global Investment Conference

Jul 24, 2018

Oramed Granted Japanese Patent for GLP-1 Analog Capsule

Jul 06, 2018

Oramed Announces Closing of $18.1 Million Registered Direct Offering

Jun 25, 2018

Oramed Enrolls First Patient in Its Glucose Clamp Study for Oral Insulin